Clinical Trial Update: Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of aliskiren 300 mg plus hydrochlorothiazide 25 mg versus aliskiren 300 mg monotherapy in patients with Stage II hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-01-21